Skip to content

Abstract A006: A p38α MAPK-TCF21 axis regulates pancreatic stellate cell activation and stromal reprogramming in pancreatic cancer

Sep 2026 · Cancer Research · Vol 86, pp. A006-A006 · 0 citations

TL;DR

Fibroblast-intrinsic p38α MAPK is established as a central regulator of the early PSC-to-CAF transition, coupling inflammatory and tumor-derived signals to chromatin remodeling and sustained stromal activation.

Abstract

Pancreatic stellate cells (PSCs) are a principal source of cancer-associated fibroblasts (CAF) in pancreatic ductal adenocarcinoma (PDAC), yet the mechanisms that convert tumor-derived inflammatory cues into a persistent, CAF-like state remain poorly defined. We previously identified tumor cell-intrinsic p38α MAPK (MAPK14) as a driver of IL1α-dependent stromal inflammation. Given its central role in integrating cellular stress and inflammatory signals, we investigated whether p38α acts as a key regulator of PSC activation and stromal reprogramming in PDAC. Human PSCs were exposed to interleukin-1α (IL-1α) or PDAC cell- conditioned media (CM) following pharmacologic inhibition or CRISPR-Cas9-mediated MAPK14 deletion. Cell state, signaling and secretory function were evaluated by immunoblotting, quantitative PCR, immunofluorescence, flow cytometry, and cytokine analysis. Bulk RNA sequencing and ATAC sequencing along with pathway and transcription factor motif analyses were integrated with human and murine PDAC transcriptomic datasets and human single-cell RNA sequencing data. TCF21 was functionally evaluated by small interfering RNA-mediated silencing. MAPK14-dependent programs were enriched in stroma-high PDAC and localized predominantly to fibroblasts in Human Tumor Atlas Network datasets. IL-1α or tumor CM activated p38α activation, reduced quiescent PSC markers FABP4 and Desmin, and increased PDGFRα, PDPN, and α-SMA. Activated PSCs secreted increased IL-6, CXCL1, CXCL2, and CXCL8. In contrast, pharmacologic inhibition and MAPK14 deletion preserved PSC quiescence and attenuated inflammatory activation, despite continued stimulation. RNA sequencing showed suppression of inflammatory, profibrotic, and extracellular matrix programs after p38α inhibition. These effects occurred without measurable changes in NF-κB activation or p65 DNA binding. ATAC-sequencing identified p38α-dependent chromatin remodeling at inflammatory regulatory loci and motif analysis identified TCF21 as a potential transcriptional mediator. TCF21 expression correlated with stromal enrichment and MAPK14 activity in human PDAC patient datasets, increased after tumor-derived stimulation, and decreased after pharmacologic inhibition or genetic deletion of p38α. TCF21 knockdown phenocopied p38α blockade, increasing FABP4 and desmin while reducing IL6 despite inflammatory stimulation. These findings establish fibroblast-intrinsic p38α MAPK as a central regulator of the early PSC-to-CAF transition, coupling inflammatory and tumor-derived signals to chromatin remodeling and sustained stromal activation. TCF21 emerges as a candidate downstream mediator of this p38α-dependent program. Selective disruption of the p38α axis may therefore reprogram pathogenic fibroblast states without indiscriminate stromal depletion, providing a mechanistically informed strategy to limit desmoplastic evolution and enhance therapeutic sensitivity in PDAC. Sayan Chakraborty, Camille Acevedo, Samara Singh, Edmond W. Box, Andrew Adams, Karthik Rajkumar, Varunkumar Krishnamoorthy, Jashodeep Datta, Nagaraj Nagathihalli, Austin Dosch, Nipun B. Merchant. A p38α MAPK-TCF21 axis regulates pancreatic stellate cell activation and stromal reprogramming in pancreatic cancer [abstract]. In: Proceedings of the AACR Conference on Pancreatic Cancer: New Frontiers in Biology and Therapeutic Development; 2026 Sep 25-28; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(18_Suppl_2):Abstract nr A006.

View source

Similar papers

Sep 2026

Abstract B001: Cancer-associated fibroblast p38α MAPK signaling coordinates collagen architecture and immune suppression to drive chemoresistance in pancreatic cancer

This work identified p38α MAPK (p38α; MAPK14) as a key regulator of inflammatory CAF activation and collagen remodeling and implicates it as a central mediator of stromal remodeling and therapeutic resistance in pancreatic cancer.

C. Acevedo, Sayan Chakraborty, Samara P. Singh et al. · 0 citations
Open access Oct 2026

Stromal CCL2/CXCL10/SPARC axes drive pro-tumor CHI3L1 expression for microenvironmental modulation in pancreatic cancer progression and therapeutic innovation

Chitinase-3-like-protein 1 (CHI3L1), a low-abundance protein in normal tissues, is markedly upregulated in the pancreatic tumor microenvironment (TME), where it promotes fibrosis and immune evasion. Spatial transcriptomics revealed enrichment of CHI3L1 at tumor-stroma interfaces, suggesting that cell-cell interactions...

Pei-Chia Su, Yanmei Shan, Ya-Chin Hou et al. · 0 citations
Sep 2026

Abstract B006: Actin Cytoskeleton Dynamics in Tumor Cells Orchestrate Stromal Desmoplasia and Immune Evasion in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is defined by a dense, immunosuppressive tumor microenvironment (TME) enriched with extracellular matrix components, cancer-associated fibroblasts (CAFs), and diverse immune populations. ChIP-seq analysis of resected human PDAC identified MICAL2 as a super-enhancer–associat...

Bharti Garg, E. Mose, Briana Nyugen et al. · 0 citations
Sep 2026

Abstract A051: CREB1 integrates EGFR/ERK and p38/LIF oncogenic inputs as a transcriptional convergence hub in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is driven by convergent oncogenic signaling; however, transcriptional regulators that integrate these pathways remain poorly understood. CREB1 is activated via the EGFR/ERK/MSK1 and p38/LIF axes, making it a potential transcriptional convergence node. The CREB1-associated c...

Rohan Moniruzzaman, K. K. Sandha, Varunkumar Krishnamoorthy et al. · 0 citations
Sep 2026

Abstract B070: Adaptive KRAS-MAPK signaling mediates resistance to CD73 blockade in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) remains highly refractory to therapy due to oncogenic KRAS signaling and an immunosuppressive tumor microenvironment. We previously established that CD73 is induced early during pancreatic tumorigenesis, where extracellular adenosine promotes disease progression through ADO...

Khadija Turabi, Shwetapadma Dash, L. Strickland et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.